PHARMAGREEN BIOTECH INC. Capital Expenditures
PHARMAGREEN BIOTECH INC. reported Capital Expenditures of $196.13 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2021-01-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2021-01-08
- PHARMAGREEN BIOTECH INC. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was -$85.33K, a 157.32% decline year-over-year.
- PHARMAGREEN BIOTECH INC. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $250.07K.
- PHARMAGREEN BIOTECH INC. payments to acquire property, plant, and equipment for the quarter ending 2019-03-31 was $20.30K.
- PHARMAGREEN BIOTECH INC. payments to acquire property, plant, and equipment for the quarter ending 2018-12-31 was $11.08K.
- PHARMAGREEN BIOTECH INC. payments to acquire property, plant, and equipment for fiscal 2019 was $196.13K, a 21.96% decline from fiscal 2018.
- PHARMAGREEN BIOTECH INC. payments to acquire property, plant, and equipment for fiscal 2018 was $251.31K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$85.33K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-08 | $164.75K derived: sum of 2 quarters · filed 2021-01-08 | $185.04K derived: sum of 3 quarters · filed 2021-01-08 | $196.13K 10-K · filed 2021-01-08 |
| 2019-06-30 | $250.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-19 | $270.37K derived: sum of 2 quarters · filed 2020-08-19 | $281.45K 10-Q · filed 2020-08-19 | $430.31K derived: sum of 4 quarters · filed 2020-08-19 |
| 2019-03-31 | $20.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-19 | $31.38K 10-Q · filed 2020-05-19 | $180.24K derived: sum of 3 quarters · filed 2020-05-19 | |
| 2018-12-31 | $11.08K 10-Q · filed 2020-02-18 | $159.94K derived: sum of 2 quarters · filed 2020-02-18 | ||
| 2018-09-30 | $148.86K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-30 | $251.31K 10-K · filed 2019-12-30 | ||
| 2018-06-30 | $102.45K 10-Q · filed 2019-08-19 |